Life Sciences Report Collection
The Life Sciences Collection spans markets that are central to the life and wellbeing of the more than 7.5 billion people on our planet. From emerging diagnostics, to brand new therapies and treatment technologies, our expert analysts know where your focus – and investment – should be when it comes to biotechnology, pharmaceuticals and healthcare. As your senior editor, I look forward to introducing you to new opportunities.
DNA Repair Drugs: Global Markets
The global DNA repair drugs market should reach $19.5 billion by 2026 from $7.5 billion in 2021 at a compound annual growth rate (CAGR) of 21.0% for the forecast period of 2021 to 2026.
Protein Sequencing: Global Market
The global market for protein sequencing should grow from $1.3 billion in 2021 to $1.6 billion by 2026 with a compound annual growth rate (CAGR) of 4.6% for the period of 2021-2026.
Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global...
The global market for circulating tumor cells (CTC) diagnostics is estimated to increase from $8.8 billion in 2021 to $15.2 billion by 2026, at a compound annual growth rate (CAGR) of 15.6% during the forecast period of 2021-2026.
Health Self-monitoring: Technologies and Global Markets
The global market for health self-monitoring technologies should grow from $48.7 billion in 2021 to $185.9 billion by 2026 with a compound annual growth rate (CAGR) of 30.7% for the period of 2021-2026.
Global Markets for Drug-Device Combinations
The global drug-device combination products market should reach $149 billion by 2026 from $103.5 billion in 2021 at a compound annual growth rate (CAGR) of 7.6% for the forecast period of 2021 to 2026.
Biobanking: Technologies and Global Markets
The global market for biobanking is estimated to increase from $61.1 billion in 2021 to $76.2 billion by 2026, at a compound annual growth rate (CAGR) of 4.5% during 2021-2026.
Pharmacy Automation: Technologies and Global Markets
The global market for pharmacy automation is estimated to increase from $6.3 billion in 2021 to $9.9 billion by 2026, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2021-2026.
Osteoarthritis Therapeutics: Global Markets
The global osteoarthritis therapeutics market should reach $11.2 billion by 2026 from $7.4 billion in 2021 at a compound annual growth rate (CAGR) of 8.6% for the forecast period of 2021 to 2026.
Therapeutics for Women's Health: Technologies and Global Markets
The global market for women’s health therapeutics should grow from $54.4 billion in 2021 to $70.8 billion by 2026 with a compound annual growth rate (CAGR) of 5.4% for the period of 2021-2026.
AI in Medical Diagnostics: Global Markets
The global market for AI medical diagnostics is estimated to increase from $748 million in 2021 to reach $4.0 billion by 2026, at a compound annual growth rate (CAGR) of 39.8% during the forecast period of 2021-2026.
In Vitro Toxicity Testing: Technologies and Global Markets
The global in vitro toxicity testing market should reach $13.3 billion by 2026 from $9.0 billion in 2021 at a compound annual growth rate (CAGR) of 8.3% for the forecast period of 2021 to 2026.
Smart Hospitals: Global Markets
The global smart hospitals market should reach $111.99 billion by 2026 from $39.16 billion in 2021 at a compound annual growth rate (CAGR) of 23.4% for the forecast period of 2021 to 2026.
Cancer Stem Cells: Technologies and Global Markets
The global market for cancer stem cells should grow from $2.1 billion in 2021 to $4.4 billion by 2026, at compound annual growth rate (CAGR) of 16.1% for the period of 2021-2026.
Wearable Medical Devices: Technologies and Global Markets
The global wearable medical devices market should reach $83.9 billion by 2026 from $20.1 billion in 2021 at a compound annual growth rate (CAGR) of 33.1% for the forecast period of 2021 to 2026.
Disabled and Elderly Assistive Technologies
The global market for assistive technology should grow from $44.1 billion in 2021 to $57.9 billion by 2026 with a compound annual growth rate (CAGR) of 5.6% for the period of 2021-2026.
Global Markets for Infectious Disease Treatments
The global market for infectious disease treatments should grow from $72.4 billion in 2021 to $106.3 billion by 2026, at compound annual growth rate (CAGR) of 8.0% for the period of 2021-2026.
Point of Care1 Diagnostics: Technologies and Global Markets
The global market for point of care diagnosis should grow from $24.8 billion in 2021 to $43.5 billion by 2026 with a compound annual growth rate (CAGR) of 11.9% for the period of 2021-2026.
Global Clinical Trial Management Systems Market
The global market for clinical trial management systems should reach $1.6 billion by 2026 from $920.8 million in 2021 at a compound annual growth rate (CAGR) of 12.2% for the forecast period of 2021 to 2026.
Current Research & Development Status of Chimeric Antigen Recepto...
The global market for chimeric antigen receptor (CAR) T-cell therapy is estimated to grow from $1.5 billion in 2021 to reach $7.6 billion by 2026, at a compound annual growth rate (CAGR) of 39.1% during 2021-2026.
Global Interventional Oncology Market
The global interventional oncology market should reach $3.1 billion by 2026 from $2.2 billion in 2021 at a compound annual growth rate (CAGR) of 7.0% for the forecast period of 2021 to 2026.
Bone Grafts and Substitutes: Global Markets
The global market for bone graft and substitutes should grow from $8.0 billion in 2021 to $11.5 billion by 2026 with a compound annual growth rate (CAGR) of 7.6% for the period of 2021-2026.
Global Market for Digital Health Technologies
The global market for digital health technologies should grow from $174.7 billion in 2021 to $384.8 billion by 2026 with a compound annual growth rate (CAGR) of 17.1% for the period of 2021-2026.
Autoinjectors: Global Markets
The global market for autoinjectors should grow from $41.5 billion in 2021 to $85.2 billion by 2026, at compound annual growth rate (CAGR) of 15.5% for the period of 2021-2026.
Global ENT Devices Market
The global ENT devices market should reach $14.1 billion by 2026 from $11.3 billion in 2021 at a compound annual growth rate (CAGR) of 4.6% for the forecast period of 2021 to 2026.
Antifungal Drugs: Technologies and Global Markets
The global market for antifungal drugs should grow from $14.5 billion in 2021 to $17.9 billion by 2026 with a compound annual growth rate (CAGR) of 4.4% for the period of 2021-2026.